Form 4: Ginkgo Bioworks Director Harry Sloan Acquires Shares Through Distribution

Sentiment:

SEC Form 4 Filing


Director Harry Sloan acquired 4,222 shares of Ginkgo Bioworks Class A Common Stock through a distribution from Eagle Equity Partners III-G LLC.

Summary

  • Harry Sloan, a director at Ginkgo Bioworks Holdings, Inc., acquired 4,222 shares of Class A Common Stock on November 22, 2024.
  • The shares were received as a distribution from Eagle Equity Partners III-G LLC.
  • Following this transaction, Mr. Sloan's direct holdings increased to 828,025 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction of share distribution, which is neither positive nor negative for the company's overall performance.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it shows continued director ownership.

Key Dates

DateDescription
11/22/2024Date of the share acquisition by Harry Sloan.

Keywords

Ginkgo Bioworks, Harry Sloan, Director, Share Acquisition, Class A Common Stock, Eagle Equity Partners, Distribution

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.